Skip to content

Clinical trials

Phase 3 COVID-19 trials in Nepal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 3 Country / region: Nepal Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20202
20213
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu Rec-Biotechnology Co., Ltd.1
Nepal Health Research Council1
Population Health Research Institute1
SK Bioscience Co., Ltd.1
Sanofi Pasteur, a Sanofi Company1
UMC Utrecht1
University of Oxford1
WestVac Biopharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-198
Community-Acquired Pneumonia2
Pneumonia2
Coronavirus Infections1
Influenza, Human1
Lung Diseases1
Respiratory Tract Diseases1
Respiratory Tract Infections1
Severe Acute Respiratory Syndrome1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.